Please login to the form below

Not currently logged in


This page shows the latest restructure news and features for those working in and with pharma, biotech and healthcare.

The new basics

The new basics

When companies are seen to be overly profit-focused, restructure ruthlessly or use aggressive tax-avoidance, these feelings are eroded quickly.

Latest news

More from news
Approximately 2 fully matching, plus 110 partially matching documents found.

Latest Intelligence

  • Building the Future Building the Future

    Firms that simply restructure and rebrand miss their opportunity and fail to adapt successfully to our changing market.

  • European sites European sites

    It offers facts and figures for international life science companies looking to expand, restructure or consolidate their activities in Europe.

  • Pharma deals during May 2014 Pharma deals during May 2014

    He postulates that “ the large hierarchical and integrated organisation structures… have run their course as the optimal structural form” and companies will restructure to become more focused in specific business areas

  • Pharma deals during October 2013 Pharma deals during October 2013

    Whilst large pharma continue to restructure and shed jobs, there does seem to be a lifeline of new companies growing and securing finance, especially in the US.

  • China: Engagement strategies China: Engagement strategies

    Besides having an effective strategy that integrates traditional and digital channels, multinational pharma needs to restructure its marketing function to capitalise fully on today's opportunities in order to succeed in

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....